Seminar 1: Refresher in sarcoma
Seminar 1: Refresher in sarcoma
Welcome aperitiv and Registration Master participants
Welcome and introduction to the Master
Brief presentation of the Master participants
Sarcoma unit
What is a sarcoma unit (ITA)
Bruno Vincenzi (IT)What is a sarcoma unit (FR)
Sylvie Bonvalot (FR)Discussion with participants: How to deal it when there is no a sarcoma unit | Debate on centralization of sarcoma
Patient Advocacy
Coffee break
Workshop: Dealing with data uncertainty
Rare cancer network
Welcome dinner in hotel
Welcome
Soft tissue sarcoma treatments
On what criteria is the WHO classification based on?
Angelo Paolo Dei Tos (IT)Molecular biology — expectations and optimal test selection for specific clinical situations
Sarah Watson (FR)Soft Tissue Sarcoma Imaging — Pitfalls and the Percutaneous Biopsy Technique
Carlo Morosi (IT)Quality criteria for appropriate surgery of soft tissue sarcoma, personalized according to histology?
Sylvie Bonvalot (FR)Coffee break
Which patients benefit from radiotherapy, and how to determine the optimal Treatment Sequencing and fractionation?
Sarcoma in the Perioperative Setting - what is approved or is optional according to the local and metastatic risks?
Metastatic Sarcoma: lights and shadows - a focus on what is validated according to the subtype
Epidemiology of sarcomas, genetic predispositions and implications:
The surgeon point of view
Dario Callegaro (IT)The medical oncologist point of view
Armelle Dufresne (FR)Clinical Case (prepared by faculty)
Silvia Brotea-mosoiu (RO)Clinical case discussion
Lunch
Bone sarcoma
Anatomoradiological Correlation and Diagnostic Approach for Bone Tumors
Medical Strategy for Localized and Metastatic Osteosarcomas
Piotr Rutkowski (PL)Metastatic Chondrosarcomas and systemic therapy
Piotr Rutkowski (PL)Tenosynovial Giant Cell Tumors (TGCTs): Tyrosine Kinase Inhibitors (TKIs) — Indications, Duration, and Treatment Sequencing
Piotr Rutkowski (PL)Coffee break
Does radiation have a role in chondrosarcoma?
Desmoids: Rationale for Active Initial Surveillance and Medical Treatment Options
Clinical case discussion
Pediatrics
Medical Strategy for Localized and Metastatic Ewing
Nathalie Gaspar (FR)Role of radiotherapy in Ewing sarcoma
Lisette Wiltink (NL)Medical Strategy for Localized and Metastatic rhadomyosarcoma
Silvia Stacchiotti (IT)Clinical case discussion
Coffee break
GISTs
Local GISTS and adjuvant treatment
Sebastian Bauer (DE)Medical options for metastatic GIST and Circulating tumour DNA (ctDNA) to monitor treatment
Sebastian Bauer (DE)Uterine sarcomas: a spectrum of tumor varieties
Clinical case discussion
Lunch
Communication workshop: breaking bad news
Clinical case discussion
Closing remarks and departures
COURSE LEADERSHIP
Chair - Sylvie Bonvalot, FR
Host Chair - Bruno Vincenzi, IT
College Representative - Silvia Brotea-Mosoiu, RO
Alina Comanescu
Digestive Cancers Europe, ., ., RO
Angelo Paolo Dei Tos
Azienda ULSS9, Anatomia Patologica Dpt., Treviso, IT
Armelle Dufresne
Centre Léon Bérard, Medical Oncology Departement, Lyon cedex 08, FR
Bruno Vincenzi
University Campus Bio-Medico, Medical Oncology Dpt., Rome, IT
Carine Ngo
Gustave Roussy, Département de Biologie et Pathologie Médicales, Villejuif,, FR
Carlo Morosi
Fondazione IRCCS Istituto Nazionale dei Tumori, Radiologia Diagnostica e Inteventistica, Milano, IT
Dario Callegaro
Fondazione IRCCS Istituto Nazionale Tumori, Struttura Semplice Chirurgia dei Sarcomi, Milano, IT
Lisette Wiltink
The Netherlands Cancer Institute, -, Amsterdam, NL
Nathalie Gaspar
Gustave-Roussy Institute, Oncology Dpt., Villejuif, FR
Paolo Bruzzi
Genova, IT
Paolo Giovanni Casali
National Cancer Institute - IRCCS Foundation, Medical Oncology Unit 2, Milan, IT
Pauline Leonard
National Health Service, Oncology and Communication Dpt., London, UK
Piotr Rutkowski
Maria Sklodowska-Curie National Research Institute of Oncology, Dept. of Soft Tissue/Bone & Melanoma, Warszawa, PL
Rick Haas
The Netherlands Cancer Institute, Dept. of Radiotherapy, Amsterdam, NL
Sarah Watson
Institut Curie Paris, Researcher and head of the Drug Development and Innovation (D3i) department at Institut Curiemedical oncologist specializing in sarcomas, researcher and head of the Drug Development and Innovation (D3i) de, Paris, FR
Sebastian Bauer
University Hospital Essen - West German Cancer Center (WTZ), Translational Sarcoma Research, Essen, DE
Sergio Valeri
Fondazione Policlinico Universitario Campus Bio-Medico, Chief Surgical Sarcoma Service – Department of Surgery, Rome, IT
Silvia Brotea-mosoiu
Oncology Institute of Bucharest, Medical Oncology Dept., Bucharest, RO
Silvia Stacchiotti
Sarcoma Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milano, IT
Sylvie Bonvalot
Institut Curie, Dept. of Surgery, Paris, FR
